Wells Fargo’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-627
| Closed | -$3K | – | 6802 |
|
|
2016
Q4 | $3K | Hold |
627
| – | – | ﹤0.01% | 6077 |
|
|
2016
Q3 | $3K | Hold |
627
| – | – | ﹤0.01% | 6030 |
|
|
2016
Q2 | $2K | Sell |
627
-3,800
| -86% | -$14.2K | ﹤0.01% | 5983 |
|
|
2016
Q1 | $14K | Hold |
4,427
| – | – | ﹤0.01% | 5608 |
|
|
2015
Q4 | $20K | Hold |
4,427
| – | – | ﹤0.01% | 5587 |
|
|
2015
Q3 | $21K | Sell |
4,427
-3,369
| -43% | -$21.8K | ﹤0.01% | 5537 |
|
|
2015
Q2 | $55K | Buy |
7,796
+6,009
| +336% | +$45.2K | ﹤0.01% | 5299 |
|
|
2015
Q1 | $15K | Buy |
1,787
+110
| +7% | +$937 | ﹤0.01% | 5502 |
|
|
2014
Q4 | $16K | Buy |
1,677
+9
| +0.5% | +$78 | ﹤0.01% | 5467 |
|
|
2014
Q3 | $14K | Sell |
1,668
-970
| -37% | -$8.98K | ﹤0.01% | 5470 |
|
|
2014
Q2 | $31K | Sell |
2,638
-283,209
| -99% | -$2.91M | ﹤0.01% | 5174 |
|
|
2014
Q1 | $3.63M | Buy |
285,847
+285,845
| +14,292,250% | +$3.69M | ﹤0.01% | 2556 |
|
|
2013
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 6338 |
|
|
2013
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 6201 |
|
|
2013
Q2 | $0 | Buy |
+2
| New | +$26 | ﹤0.01% | 5926 |
|
Other funds holding DSCI
Wells Fargo's DSCI Position: Q1 2017 in Review
Wells Fargo sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 627 shares — an estimated $3K sold.
Wells Fargo first reported a position in DSCI in Q2 2013 and held it in 15 quarters. The position peaked at $3.63M in Q1 2014. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.
- Wells Fargo reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
- Wells Fargo sold 627 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $3K.
- Wells Fargo first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 15 quarters.
- Wells Fargo's Derma Sciences, Inc. Common Stock (DE) position peaked at $3.63M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.
Based on Wells Fargo's 13F filing for Q1 2017, filed 28 Apr 2017.